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In order to improve the diagnosis of Listeria meningitis or meningoencephalitis, especially in patients who
have received antibiotics before their cerebrospinal fluid (CSF) has been examined, two assays for the detection
of Listeria monocytogenes based on the polymerase chain reaction (PCR) were evaluated. After a standard
PCR, the amplified DNA was detected either by a second round of PCR with internal primers followed by gel
electrophoresis and ethidium bromide staining (nested PCR) or by dot blot hybridization to an internal
digoxigenin-labeled probe (PCR-dot blot). For PCR, two sets of primers within the invasion-associated protein
gene (iap gene) were chosen. They allowed for the highly specific detection of all L. monocytogenes reference
strains tested (serotypes 1/2a, 1/2b, 1/2c, 3a, 3b, 3c, 4a, 4b, 4c, 4d, and 7). These primers did not detect
amplification products from various other gram-positive or gram-negative bacterial DNAs or human DNA. The
sensitivities ofboth assays were assessed on sterile CSF samples that were artificially seeded with serial dilutions
of L. monocytogenes serotype 4b cells. By both methods the limit of detection was <10 cells in the initial
reaction. Since the nested PCR is more prone to contamination because of manipulation of the amplified
products, a standard PCR assay followed by dot blot hybridization was applied to 52 CSF samples in a
retrospective study. Of 28 CSF samples which were sterile or positive for bacteria other than Listeria species,
24 were PCR negative. In contrast, from 17 patients with culture-proven Listeria meningitis, 14 of 17 initial
CSF samples were PCR positive, as were 3 of 7 culture-negative follow-up CSF samples taken after patients
received antibiotics. These results support the usefulness of this approach in the diagnosis ofListeria meningitis,
in particular, when antibiotic administration precedes culture of CSF.
The increase in the incidence of human listeriosis in
developed countries and the recent association of severe
Listeria monocytogenes infections with food-borne out-
breaks have stimulated research on new diagnostic proce-
dures. In humans, L. monocytogenes mainly causes menin-
gitis, encephalitis, or septicemia in nonpregnant adults.
When it infects the central nervous system, L. monocyto-
genes leads to severe disease with a high mortality rate (20 to
50%) and neurological sequelae among the survivors. There-
fore, this infection requires prompt recognition and therapy
(21).
The diagnosis of Listeria meningitis, meningoencephalitis,
or septicemia is based on the culture of cerebrospinal fluid
(CSF) and blood. The direct examination of Gram-stained
clinical specimens is generally of little value, because L.
monocytogenes is often present in low numbers in some
samples, particularly in CSF, at the time of presentation.
Furthermore, in some cases, antibiotics have already been
administered to the patient before the CSF can be cultured,
thus hampering the diagnosis.
Use of polymerase chain reaction (PCR) technologies for
the detection of low numbers of L. monocytogenes in food
samples has been reported (1, 3, 5, 8, 10, 22). To our
knowledge, no PCR has been tested with human clinical
samples. Several genes specific for Listeria species, which
could serve as targets in a PCR, have been sequenced (6, 7,
9, 15). One of them, the iap gene, encodes the invasion-
associated protein p60 (11), which may be involved in the
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invasion process (12). Kohler et al. (11) showed that syn-
thetic probes previously described as specific for the detec-
tion of the presumptive p-hemolysin gene of L. monocyto-
genes by colony hybridization (4) are in fact part of the iap
gene. Therefore, the iap gene seems an appropriate target for
the detection of L. monocytogenes by PCR.
We report here a description and comparison of two PCR
assays for the detection of L. monocytogenes DNA in
human CSF samples. The first assay is a two-step PCR
followed by gel electrophoresis and ethidium bromide (EtBr)
staining (nested PCR), and the second one is a standard PCR
followed by dot blot hybridization with a digoxigenin-labeled
probe (PCR-dot blot). We found that the latter methodology
is sensitive enough to detect fewer than 10 cells. Its appli-
cation was suitable for the retrospective diagnosis of L.
monocytogenes in 52 clinical CSF samples collected be-
tween 1983 and 1991.
MATERIALS AND METHODS
Bacterial strains. The following bacterial strains were used
in this study: (i) 18 reference or type strains representing all
known Listeria species and all L. monocytogenes serotypes
(H. P. R. Seeliger, University of Wurzburg, Wurzburg,
Germany) except L. monocytogenes serotype 4ab (Table 1);
(ii) 16 L. monocytogenes serotype 4b strains isolated from
different patients during the outbreak of listeriosis in Canton
de Vaud (Switzerland) (2); one of them (strain K27) was used
for the serial dilution assays; (iii) 15 strains of gram-positive
bacteria other than Listeria species (Table 2); (iv) 7 strains of
Haemophilus influenzae isolated from CSF samples in the
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TABLE 1. Species, serotypes, and source of the Listeria strains
used in this study
Species Serotype Sourcea
L. monocytogenes 1/2a NCTC 7973
L. monocytogenes 1/2b SLCC 2755
L. monocytogenes 1/2c NCTC 5348
L. monocytogenes 3a NCTC 5105
L. monocytogenes 3b SLCC 2540
L. monocytogenes 3c SLCC 2479
L. monocytogenes 4a NCTC 5214
L. monocytogenes 4b NCTC 10527
L. monocytogenes 4c NCTC 4883
L. monocytogenes 4d ATCC 10888
L. monocytogenes 4e ATCC 19118
L. monocytogenes 7 SLCC 2482
L. innocua 6a NCTC 11288
L. ivanovii 5 ATCC 19119
L. welshimeri 6a SLCC 5334
L. seeligen 1/2b CIP 100100
L. murrayi ATCC 25403
L. grayi ATCC 19120
L. monocytogenes (16 4b Human clinical isolates
strains including K27)b
a NCTC, National Culture Type Collection, Central Public Health Labora-
tory, London, England; SLCC, Special Listeria Culture Collection,
Wurzburg, Germany; ATCC, American Type Culture Collection, Rockville,
Md.; CIP, Institut Pasteur Collection, Paris, France.
b The 16 strains were wild-type strains. All other strains listed here were
reference or type strains.
Centre Hospitalier Universitaire Vaudois and 2 strains of
Neisseria meningitidis.
All strains were kept in skim milk at -80°C. They were
streaked onto 5% human blood Columbia agar (Oxoid,
Unipath Ltd., Basingstoke, England). H. influenzae and N.
meningitidis strains were streaked onto chocolate Columbia
blood agar (Oxoid). All the plates were incubated for 24 h at
37°C. One colony was then inoculated in Todd-Hewitt broth
(Difco Laboratories, Detroit, Mich.) and was incubated
overnight at 37°C before DNA preparation.
Human CSF samples. A total of 52 CSF samples from 44
TABLE 2. Genus, species, and source of bacteria other than
Listeria species used in this study
Genus and species Sourcea
Brochothrix thermosphacta .............. ...... CIP 69.6
Cellulomonas turbata ....... .............CIP 100331 T
Corynebacterium xerosis.................... NCTC 9755
Enterococcus avium................... ATCC 14025
Enterococcus durans.................... ATCC 19432
Enterococcus faecalis.................... ATCC 29212
Erysipelothrix rhusopathiae .................... BTCC 65
Haemophilus influenzae.................... Wild-type strains
Jonesia denitnificans.................... ATCC 14870
Kurthia zopfii....................NCTC 10597
Lactobacillus casei ...... ..............ATCC 393
Neisseria meningitidis .................... Wild-type strains
Staphylococcus aureus ....... ............ Wild-type strain
Staphylococcus epidermidis.................... Wild-type strain
Streptococcus agalactiae ......... .......... Wild-type strain
Streptococcus pneumoniae................... Wild-type strains
a CIP, Institut Pasteur Collection, Paris, France; NCTC, National Culture
Type Collection, Central Public Health Laboratory, London, England;
ATCC, American Type Culture Collection, Rockville, Md.; BTCC, Bulgarian
Type Culture Collection, Sofia, Bulgaria.
patients were tested (see Table 4), as follows: (i) 14 sterile
CSF samples from 13 patients with nonbacterial meningitis
or no CSF infection; half of them were collected during the
Swiss outbreak of listeriosis (1983 to 1987) (2); (ii) 14 CSF
samples positive for microorganisms other than Listena
species, as follows: N. meningitidis (n = 2), Staphylococcus
aureus (n = 1), Staphylococcus epidennidis (n = 2), Strep-
tococcus agalactiae (n = 1), Streptococcus pneumoniae (n
= 2), H. influenzae (n = 5), and Cryptococcus neoformans
(n = 1); 10 of the samples were collected during 1983 to 1987,
two were collected in 1988, and two were collected in 1991;
(iii) 24 CSF samples from 17 patients with culture-proven
Listenia meningitis; 17 samples were positive for L. mono-
cytogenes by culture at the time of presentation; the other 7
samples were negative by culture and were follow-up sam-
ples taken between 2 and 15 days after the patient had
started antibiotic treatment. All CSF samples except two
were collected during the Swiss outbreak of listeriosis (1983
to 1987) (2).
All specimens were divided into aliquots and were stored
at -20°C without any particular precautions, as would now
be required for studies involving PCR (13, 18).
DNA preparation. (i) DNA extraction. DNA was purified
from bacteria by the method of Le Febvre et al. (14), with
some modifications (16). Cells from a 1.5-ml overnight
culture or from chocolate agar plates incubated overnight
were harvested and washed in 10 mM Tris-HCl (pH 8.0)-i
mM EDTA-100 mM NaCl. After centrifugation the pellets
were resuspended in 25 mM Tris-HCl (pH 8.0)-10 mM
EDTA-50 mM glucose. Cells were then treated with lyso-
zyme (Sigma Chemical Co., St. Louis, Mo.) at 10 mg/ml and
RNase A (Boehringer, GmbH, Mannheim, Germany) at 200
,ug/ml at 37°C for 30 min. Proteinase K (Sigma) and sodium
dodecyl sulfate were then added at 200 ,g/ml and 1%
(wt/vol), respectively, and the samples were incubated at
50°C for 60 min. DNA was extracted three times with 1
volume of phenol-chloroform-isoamyl alcohol (25/24/1). The
aqueous phase was recovered and adjusted to 0.3 M sodium
acetate, and nucleic acids were precipitated with 0.6 volume
of isopropanol at room temperature for 5 min. The DNA was
centrifuged, washed with 70% ethanol, and air dried. The
pellets were resuspended in 40 RI of 10 mM Tris-HCl-0.1
mM EDTA (pH 7.5). For quantification, DNA was electro-
phoresed through a 0.8% agarose gel containing 0.5 ,ug of
EtBr per ml. The DNA was then revealed under UV light,
and the fluorescence of the bacterial band was compared
with that of a known amount of HindIII-digested bacterio-
phage A DNA.
(ii) Crude lysates of bacterial cells. Cells of L. monocyto-
genes serotype 4b (human isolate K27) from an overnight
culture were serially diluted in 500 pl of sterile 0.9% NaCl.
After centrifugation for 10 min in an Eppendorf centrifuge,
the pellet from each dilution was resuspended in 1 ml of
sterile water and 10 RI of each suspension was plated onto
blood agar for CFU counts. The suspension was then left for
1 h at room temperature prior to DNA release by boiling for
10 min. PCR was done with 10 [lI of the lysate.(iii) Artificially seeded CSF samples. L. monocytogenes
serotype 4b (human isolate K27) from an overnight culture
was serially diluted in 200 RI of pooled sterile human CSF
containing between 50 and 500 x 106 leukocytes per liter.
After centrifugation for 10 min, the pellet of each dilution
was suspended in 100 RI of sterile water and 10 ,ul of each
suspension was plated onto blood agar for CFU counts.
Each dilution was then left at room temperature for 1 h.
Since bacteria were in a small volume, their DNA was
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TABLE 3. Sequences of the oligonucleotide primers and their
locations in the iap gene
Name Sequence (5' to 3') Location Product
External
iap-A CAA.AGGTGGAT&CC&AA.AGTAACTGT 760-783 468
iap-B TGGAGCTTCCGAaAaTTCACTTCTG 1228-1206
Internal
iap-l CGAATCTAACGGCTGGCACA 793-812 287
iap-3 GCCCAAATAGTGTCACCGCT 1080-1061
a One mismatch was introduced at these positions for cloning purposes.
released by freezing at -80°C and boiling five times for 30 s
each time rather then boiling once for 10 min. PCR was done
with 10 pl of the lysate.
(iv) Human CSF samples. Two hundred microliters of CSF
was centrifuged for 10 min in an Eppendorf centrifuge. The
pellets were suspended in 100 ,u of sterile water, and DNA
was released by freezing and boiling five times as described
above. PCR was done with 10 p1 of the lysate. All samples
were tested at least twice.
PCR. (i) Oligonucleotide characteristics. Primers were cho-
sen from the invasion-associated protein gene (iap gene) on
the basis of the sequence reported by Kohler et al. (11).
Specific data on the two pairs of oligonucleotide primers are
given in Table 3. The external primers iap-A and iap-B
delimit a 468-bp segment of the iap gene of L. monocyto-
genes. The internal primers iap-1 and iap-3 delimit a 287-bp
segment within the 468-bp product. iap-3 was used as a
probe in the dot blot assay to identify the PCR product
obtained with the external primers (iap-A and iap-B).
(ii) Standard PCR. PCR (19) amplification was performed
with 10 ,u ofDNA preparation in a 50-pI reaction containing
50mM Tris-HCl (pH 8.8)-1.5 mM MgCl2-50 mM KCl-0.01%
gelatin-0.1% Triton X-100, 200 pM (each) four deoxynucle-
otide triphosphates, and primers iap-A and iap-B or iap-1
and iap-3 at 0.8 or 1 p,M, respectively. The samples were
overlaid with 50 VI of paraffin oil. The PCR was done with a
Techne PHC 2 thermal cycler. Positive (0.05 ng of L.
monocytogenes serotype 4b DNA) and negative (no DNA)
controls were included in each set of PCRs.
(iii) Cycling. The precycle consisted of 97°C for 5 min and
74°C for 1 min, 1 U of Taq polymerase (Cetus) was added,
annealing was done at 50°C for 1 min, and extension was
done at 74°C for 2 min. For cycles 1 to 30, denaturation was
done at 94°C for 30 s, primer annealing was done at 50°C for
1 min, and extension was done at 74°C for 1 min, with an
additional extension step at 74°C for 5 min at the end of the
last cycle.
(iv) Nested PCR. A new PCR was performed by using 10 VI
of the standard PCR as a template. Buffer, deoxynucleotide
triphosphates, internal primers iap-1 and iap-3 at 1 puM, and
Taq polymerase were added. The reactions were then sub-
jected to an additional 30 cycles of amplification as described
above.
(v) Negative controls. At the time of DNA preparation,
every fourth or fifth sample was an internal negative control,
in which water replaced DNA. All the clinical CSF samples
were given a code and assayed by one of the investigators
(K.J.), who was unaware of the culture results. The samples
that were negative by the standard PCR were tested for
inhibitors. For this, human placental DNA (1 ng) was added
to the CSF sample together with human leukocyte antigen
DQa primers (20), and PCR was done by using the same
conditions as those for the standard PCR. The target of these
primers was the human leukocyte antigen locus. An ampli-
fied product of 227 bp was expected if no inhibitors of the
amplification were present in the sample.
Detection of the amplification products. (i) Electrophoresis
and ethidium bromide staining. Ten microliters of each
reaction was electrophoresed for approximately 30 min at 10
V/cm through a 3% Nusieve GTG agarose gel (FMC Bio-
products, Rockland, Maine) containing 0.5 ,ug of EtBr per
ml. DNA was revealed under UV light.
(ii) Dot blot hybridization. Three microliters of the ampli-
fied product of the standard PCR was applied to a nylon
membrane (Boehringer). DNA was denatured in 0.5 N
NaOH-1.5 M NaCl for 5 min and was then neutralized with
1 M Tris-HCI (pH 7.5)-1.5 M NaCl three times for 2 min
each time. The membrane was then rinsed in 2x SSC (1 x
SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 2 min
and was baked at 120°C for 30 min. Prehybridization was
performed at 52°C for more than 1 h in 3 M tetramethylam-
moniumchloride (TMAC)-50 mM Tris-HCI (pH 8.0)-1%
blocking reagent (Boehringer)-0.02% sodium dodecyl sul-
fate-0.1% N-lauryl sarcoside-50 p.g of salmon sperm DNA
per ml. The prehybridization solution was then replaced with
an identical solution containing the iap-3 probe at 1 nM, and
hybridization was allowed to proceed for more than 2 h at
52°C. The probe was prepared by labeling the 3' end of the
internal primer iap-3 with digoxigenin-dUTP by using termi-
nal transferase as recommended by the manufacturer
(Boehringer). After the hybridization, the membrane was
washed twice at 62°C for 15 min in 3M TMAC-50 mM
Tris-HCI (pH 8.0). Immunoenzymatic detection of the hy-
bridized probe was performed with an anti-digoxigenin
antibody coupled to alkaline phosphatase by using 3-(2'-
spiroadamantane)-4-methoxy-4-(3"-phosphoryloxy)-phenyl-
1,2-dioxetane (AMPPD; Boehringer) as a substrate, as rec-
ommended by the manufacturer. The chemiluminescence
reaction was revealed by exposure of the membrane to X-ray
film for 2 h.
RESULTS
We used the PCR methodology to improve the diagnosis
of L. monocytogenes meningitis. Initially, 30 cycles of PCR
(standard PCR) were performed with 10-fold dilutions of L.
monocytogenes DNA (from 5 to 0.05 ng, corresponding to
106 to 104 cells, respectively) by using the external primers
iap-A and iap-B or the internal primers iap-1 and iap-3. The
amplification products were clearly detectable after agarose
gel electrophoresis and EtBr staining (Fig. 1). To assess
whether these primers were specific for L. monocytogenes,
0.05 ng of DNA from 34 Listeria strains and 24 non-Listenia
strains was used as template for the PCR. DNA from strains
representing all serotypes of L. monocytogenes gave a single
amplified product of the expected size. For L. ivanovii
ATCC 19119 and L. welshimeri SLCC 5334, DNA could be
amplified with the external primers, whereas no product was
found with the internal primers. This suggests that iap-A and
iap-B are not specific for L. monocytogenes, whereas iap-1
and iap-3 are. Therefore, the specificity for L. monocyto-
genes detection is provided by the iap-l and iap-3 primers.
No amplification products were detectable with DNA from 7
H. influenzae strains, 2 N. meningitidis strains, or 15 gram-
positive bacteria other than Listeria species or with human
DNA.
To determine the level of sensitivity of the standard PCR
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FIG. 1. Agarose gel electrophoresis of PCR-amplified products
from 10-fold dilutions of lysates of L. monocytogenes serotype 4b
cells (strain K27) ranging from 106 to 104 cells (A) and DNA
extracted from L. monocytogenes ranging from 5 to 0.05 ng (B).
Lane 1, molecular size markers; lanes 2 to 4, standard PCR with the
external primers iap-A and iap-B; lanes 5 to 7, standard PCR with
the internal primers iap-1 and iap-3; lanes 8 to 10, nested PCR; lane
11, negative control of the standard PCR; lane 12, negative control
of the nested PCR.
assay, serial dilutions ofDNA of a human L. monocytogenes
serotype 4b strain (K27) were used as templates with either
the external primers (Fig. 2A) or the internal primers (Fig.
2B). After 30 cycles of amplification, the specific products
were still detectable by EtBr staining when 5 x 10-3 ng of
DNA (corresponding to 103 cells) served as template. Since
this level of sensitivity was not satisfactory, we improved it
using the nested primer methodology (nested PCR).
L. monocytogenes DNA from an aliquot of the reaction
done with the external primers was reamplified for an
additional 30 cycles by using the internal primers iap-1 and
iap-3. An aliquot of the reaction was then submitted to gel
electrophoresis, and the DNA was stained with EtBr. The
specific 287-bp amplification product was still detected when
DNA corresponding to 5 x 10-5 ng (equivalent to 10 cells)
was used as a template in the reaction (Fig. 2C). The level of
detection was thus enhanced at least 100-fold up to the
theoretical detection limit with this nested-PCR procedure





FIG. 2. Agarose gel electrophoresis of PCR-amplified products
from 10-fold dilutions of purified L. monocytogenes DNA. (A)
Standard PCR with iap-A and iap-B primers giving a 468-bp product.
(B) Standard PCR with iap-1 and iap-3 primers giving a 287-bp
product. (C) Nested PCR. Lane 1, molecular size markers; lanes 2 to
8, dilutions ranging from 5 to 5 x 10-6 ng; lane 9, negative controls.
FIG. 3. (A) Agarose gel electrophoresis of PCR-amplified prod-
ucts from CSF artificially seeded with 10-fold dilutions of L.
monocytogenes cells. Lane 1, molecular size markers; lanes 2 to 6,
dilutions of L. monocytogenes cells ranging from 4 x 104 to 4 cells;
lane 7, negative controls of the standard PCR and the nested PCR;
lanes e, standard PCR with the external primers iap-A and iap-B;
lanes i, standard PCR with the internal primers iap-1 and iap-3; lanes
N, nested PCR. (B) Dot blot analysis of the amplified products from
the standard PCR. Lanes 2 to 7 are the same as those described
above for panel A.
compared with that of the standard PCR. When dilutions of
crude L. monocytogenes cell lysates instead of purified DNA
were used in the PCR, the sensitivity level was the same
(data not shown).
Detection of L. monocytogenes in artificially seeded CSF
samples. In order to mimic a clinical situation, sterile CSF
samples were artificially seeded with serial dilutions of L.
monocytogenes serotype 4b (strain K27). Four hundred
bacteria corresponding to 2 x 104 cells per ml of CSF were
detectable by the standard PCR assay after electrophoresis
and EtBr staining (Fig. 3, lanes e and i). By the nested PCR
approach, as few as four bacteria, corresponding to 200 cells
per ml of CSF, were detectable, again increasing the sensi-
tivity to its theoretical limit (Fig. 3, lanes N). Since this
procedure involves handling of amplified DNA, it is more
prone to contamination and may not be suitable. Therefore,
to increase the sensitivity without increasing the risk of
contamination, a more sensitive method was used to detect
the amplification product of the standard PCR. For this, the
internal primer iap-3 was labeled with digoxigenin and was
used as a probe for the detection of the 468-bp amplified
product in a dot blot assay (PCR-dot blot). With this nonra-
dioactive probe, 4 cells (equivalent to 200 cells per ml of
CSF) were detected (Fig. 3B). This level of sensitivity was
the same as that for the nested PCR procedure.
Application of the PCR and dot blot methodology to clinical
CSF samples. The PCR-dot blot methodology was used for
the detection of L. monocytogenes in 52 CSF samples (Table
4 and Fig. 4). All 14 sterile CSF samples from patients
without meningitis were PCR-dot blot negative (Table 4).
Of 14 CSF samples that were positive for microorganisms
other than L. monocytogenes, 10 were negative by PCR-dot
blot, whereas 4 were positive (Table 4). All four were culture
positive for H. influenzae and represented false-positive
specimens under our experimental conditions. The DNAs
extracted from the corresponding four H. influenzae strains
were tested by PCR, dot blot, and Southern blot analyses.
None of the DNAs could be detected, thus excluding non-
specific amplification with the iap-A and iap-B primers and
nonspecific hybridization of the iap-3 probe (data not
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TABLE 4. Detection of L. mnonocytogenes in clinical CSF
samples by comparison of conventional culture and PCR-dot blot
CSF samples Cultur PCR-dot
(no. of samples; no. of patients) samples Clue blot(Total n = 52)
Sterile CSF (14; 14) 14 _ _
CSF positive for organisms other 10
than L. monocytogenes (14; 13) 4 - +
CSF from patients with culture- 14 + +
confirmed Listena meningitis 4
(24; 17) 3 + _
3 - +
shown). In addition, all PCR-negative controls (in two inde-
pendent PCR runs) were negative, thus reasonably excluding
contamination at the time of the PCR assay. These CSF
samples may have been contaminated previously during
storage and/or manipulation.
Of 24 CSF samples collected from 17 patients with culture-
confirmed Listeria meningitis, 14 were PCR-dot blot hybrid-
ization and culture positive and four were negative by both
techniques (Table 4).
Three other CSF samples which were culture positive for
L. monocytogenes remained PCR-dot blot negative. One
was a supernatant from the original CSF sample. The second
was positive in one broth only after 72 h. The third PCR-dot
blot false-negative CSF sample probably contained very few
bacteria because none of two solid media and one of two
broth culture media only was positive at the time of presen-
tation. No PCR inhibitors could be found in these three
samples or in any other negative samples. DNA from the L.
monocytogenes strains in two of these CSF samples was
extracted, and 0.5 ng of this DNA was submitted to the
PCR-dot blot methodology. A strong positive signal was
obtained, suggesting that these false-negative results were
not due to a lack of specificity of our primers. These negative
results by PCR-dot blot probably reflect the low concentra-
tions of L. monocytogenes in these CSF samples (fewer than
400 cells per ml). Finally, three other samples negative by
culture were positive by PCR-dot blot. All three samples
1 2 3 4 5 6
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FIG. 4. Dot blot analysis of amplified CSF samples probed with
digoxigenin-labeled iap-3 oligonucleotide. (A) Lane 1, positive con-
trol; lane 2, H. influenzae culture-positive CSF (false-positive re-
sult); lane 3, C. neoformans culture-positive CSF; lane 4, N.
meningitidis culture-positive CSF; lane 5, sterile CSF; lane 6,
positive control. (B) Lane 1, L. monocytogenes serotype 4b culture-
positive CSF; lane 2, L. monocytogenes serotype 4b culture-positive
CSF; lane 3, L. monocytogenes serotype 4b culture-negative sample
(follow-up of a positive CSF); lane 4, L. monocytogenes serotype 4b
culture-positive CSF; lane 5, L. monocytogenes serotype 4b culture-
positive CSF; lane 6, negative control. A2 and B3 were well seen on
the original X-ray film.
were follow-up CSF samples (2, 2, and 15 days, respectively)
from patients with a previous CSF sample that was positive
for L. monocytogenes by culture and who were already
treated with antibiotics. These data suggest that nonviable
cells can be detected by PCR-dot blot.
DISCUSSION
In order to improve the diagnosis of Listeria meningitis,
especially after antibiotic administration, we developed and
compared two PCR-based procedures. A nested PCR assay
followed by gel electrophoresis and EtBr staining was com-
pared with a standard PCR assay followed by dot blot
hybridization. Two sets of primers were selected within the
iap gene (11). The selected oligonucleotides allowed the
detection of all L. monocytogenes reference strains tested.
The external primers (iap-A and iap-B) were not specific for
L. monocytogenes, because they allowed the amplification
by PCR of DNA from two non-L. monocytogenes reference
strains. However, the internal primers iap-l and iap-3 pro-
vided specificity for the detection of L. monocytogenes by
the nested PCR, with iap-3 providing the specificity for the
dot blot hybridization assay. This difference between both
pairs of primers was not surprising. It is known that the
specificity of a PCR highly depends on the 3'-end sequence
of the primers and that one mismatch in this region may
result in no amplification.
We, like others, have observed that purification of the
bacterial DNA is not necessary for PCR (1, 3, 17). Thus, the
use freeze-thaw lysates of CSF reduces the need for manip-
ulation of the clinical samples and could diminish the risk of
false-positive results because of contamination.
Under our experimental conditions, the standard PCR
assay for the direct detection of L. monocytogenes had a
sensitivity of 1,000 to 400 viable cells. Because the theoret-
ical limit of detection by PCR is on the order of one copy of
the target sequence initially in the reaction, we assessed
whether this limit could be obtained. Indeed, this was
achieved by increasing the number of amplification cycles in
the nested methodology or by increasing the sensitivity of
PCR product detection in the hybridization procedure. The
nested PCR methodology can be completed in 8 h. However,
its routine application in a standard microbiological setting
may be difficult because of the high risk of contamination
(13, 18). Although the dot blot methodology is more time-
consuming (more than 24 h to complete), it is less susceptible
to contamination. Thus, it may be more useful in a diagnostic
laboratory.
For the reasons mentioned above, we chose the PCR-dot
blot methodology to examine 52 CSF samples collected
between 1983 and 1991. All four false-positive results ob-
tained by PCR-dot blot were obtained with CSF samples
which were positive by culture for H. influenzae. This was
very intriguing but could not be explained by a lack of
specificity of the reaction. When DNA from each of the four
H. influenzae strains was used as a template in the PCR, no
amplification product could be detected by Southern blotting
or dot blotting with the iap-3 probe (data not shown). All the
experiments were done at least twice, with negative controls
performed at each step. Physical separation of the pre- and
postamplification procedures, separate sets of supplies and
pipetting devices for setting up reactions, and positive-
displacement pipettes were used to avoid contamination,
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according to current standards for performing DNA ampli-
fication (13, 18). Contamination during the performance of
the assay could thus be reasonably excluded. These false-
positive results might result from a contamination of the
samples during collection, storage, and subsequent manipu-
lations. They were all collected during the period of the
Swiss outbreak of listeriosis (1983 to 1987) (2) and were
manipulated in the same laboratory where the true-positive
specimens and all the strains of L. monocytogenes related to
the epidemic were investigated. At that time, the possibility
of doing DNA amplification was not considered, and appro-
priate care was not necessarily applied to the sampling of the
specimens. Our results stress the fact that clinical samples
must be manipulated with special caution when a nucleic
acid amplification assay is to be used.
A positive signal could be obtained with 14 of 17 CSF
samples positive for L. monocytogenes by culture and tested
after 1 to 7 years of storage. Three additional specimens that
were culture positive for L. monocytogenes were PCR-dot
blot negative. No PCR inhibitors were found in these three
false-negative specimens. The amount of L. monocytogenes
could have been minimal in these samples, reaching the limit
of sensitivity of the method.
Three other CSF samples collected from patients with
Listeria meningitis were culture negative and PCR-dot blot
positive. All three samples were follow-up CSF samples
taken from patients with a previous CSF culture that was
positive for L. monocytogenes, and who had already been
treated for 2 or more days with antibiotics. In that situation,
PCR-dot blot may be more sensitive than conventional
culture because it can detect cells even though they are
dead. For this reason, these results were not considered
false positive. They suggest that standard PCR followed by
dot blot hybridization is an encouraging approach for the
diagnosis of Listeria meningitis, in particular, when antibi-
otic administration precedes culture of CSF.
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